Shares in Pringles and Pop Tarts maker, Kellanova, surged by 16% this week after it was reported that confectionery, food and pet care conglomerate Mars is preparing to buy it. That would be “one of the year’s biggest takeovers”, says the Financial Times.
Mars is one of the world’s largest privately held companies, with annual sales of more than $50 billion and more than 150,000 employees. The news also comes as Kellanova has “appeared to weather the slowdown in US consumer spending”, raising its full-year sales forecasts last week after its latest earnings “surpassed expectations”. The shares had gained 15% this year before the bid.
Should you buy Kellanova shares?
Buying Kellanova makes sense, say Crystal Tse and Deena Shanker on Bloomberg. It would give Mars “a greater variety of food labels including Pringles, Cheez-It and Pop Tarts”. It would also help Mars diversify its “chocolate-heavy brand portfolio” away from cocoa, “a commodity whose prices have spiked to historic levels this year and whose outlook remains uncertain”.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Kellanova would also help Mars fight back against “declining volumes, slowing growth and a weakening global consumer”. While there are other potential acquirers, including Mondelez International, a purchase by Mars would face less regulatory scrutiny as Mars has less overlap with Kellanova than other brands.
The financial logic of the deal “can just about work, too”, says Jennifer Saba on Breakingviews. There could be nearly $1 billion of synergies. However, the timing “may seem odd”, as Procter & Gamble, McDonald’s and even Amazon have noted that shoppers “are becoming much more discerning on price”.
Meanwhile anti-obesity drugs from Novo Nordisk, Eli Lilly and others “threaten consumption of empty-calorie treats”. Still, “if the market is getting tougher, bulking up to take a bigger piece of it is a textbook defence”.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
-
MoneyWeek news quiz: Which G7 nation has the most generous state pension?The chancellor “set the context” for the Budget on 26 November this week, and November's Premium Bonds winners were confirmed. The state pension also made headlines. How closely have you been following the news?
-
Have a will? It may not be enough to secure your wishes – here’s what you need tooIncorporating a letter of wishes into your estate planning can provide a unique opportunity to personally guide your loved ones on your final wishes for them and you. We explain how a letter of wishes works.
-
The Stella Show is still on the road – can Stella Li keep it that way?Stella Li is the globe-trotting ambassador for Chinese electric-car company BYD, which has grown into a world leader. Can she keep the motor running?
-
Global investors have overlooked these solid stocks going for growthOpinion Nisha Thakrar, investment specialist at Nedgroup Investments, selects three undervalued stocks with long-term growth potential
-
LVMH is set to prosper as the wealthy start shopping againAfter two years of uncertainty, the outlook for LVMH is starting to improve. Is now a good time to add the luxury-goods purveyor to your portfolio?
-
Japan is still rising to new highs – here's how to investOpinion Political ructions in Japan are no obstacle to gains, and the return of inflation may even benefit stocks, says Max King. What is Japan doing right?
-
Investors need to get ready for an age of uncertainty and upheavalTectonic geopolitical and economic shifts are underway. Investors need to consider a range of tools when positioning portfolios to accommodate these changes
-
Investing in UK universities: how to spin research into profitsUK universities are a vital economic asset, but they are also Britain's 'equivalent of Gulf oil.' There are opportunities here for investors
-
AI is a bet we’re forced to makeIt’s impossible to say yet if AI will revolutionise the world, but failure would clearly be very costly, says Cris Sholto Heaton
-
The MoneyWeek Wealth Summit 2025: how to invest for a volatile eraMoneyWeek's 25th birthday conference’s agenda offers investors a wide array of compelling themes
